1. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.
   Chen-Kai Chou et al, 2017, Int J Mol Sci CrossRef
2. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
   Bao-Min Shi et al, 2017, WJG CrossRef
3. Epigenetic modifications in poorly differentiated and anaplastic thyroid cancer
   Thanyawat Sasanakietkul et al, 2018, Molecular and Cellular Endocrinology CrossRef
4. miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21
   Ruzhen Zheng et al, 2017, Biomedicine & Pharmacotherapy CrossRef
5. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis
   Jian Chen et al, 2020, Aging CrossRef
6. Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
   Alessandro Prete et al, 2021, Cancers CrossRef
7. Cell cycle associated miRNAs as target and therapeutics in lung cancer treatment
   Atqiya Fariha et al, 2022, Heliyon CrossRef
8. Modulating gene expression as a strategy to investigate thyroid cancer biology
   Diego Claro de Mello et al, 2024 CrossRef